GOOD READS | OUR SPECIALTY IN THE NEWS
ACAAI in the news: ACAAI creates plan to tackle racial disparities in atopic disease, food allergy.
Join the AMA president, U.S. Surgeon General and other physician wellness experts for a webinar on physician burnout on March 9, 2023 at 11:00 am CT. Register now.
The NIH is conducting a study of a month-long treatment to examine the efficacy and safety of remibrutinib, a BTK inhibitor, in patients with peanut allergy. The primary endpoint is evaluated by the ability to tolerate 600 mg of peanut protein. Participating sites are open in USA, Spain and Italy. |